Skip to main content

Table 1 Exosomal and autophagic proteins as potential biomarkers

From: Synergies in exosomes and autophagy pathways for cellular homeostasis and metastasis of tumor cells

Cancer type

Exosomal proteins as biomarker

Autophagic proteins as biomarker

Bladder

α6-integrin, Basigin, TACSTD2, Mucin4, EDIL-3, EPS8L2, MUC-1 [169]

NR

Breast

Survivin, Survivin-2B, CEA, Tumor antigen15-3 [170]

LC3β [171], LC3α [172], ULK-1 [173], Beclin-1 [174], FIP200 [175]

Cervical

ATF1, RAS [176]

NR

Colorectal

CEA [110]

Beclin1, LC3β [174]

Gastric

NR

ULK1, Beclin 1, ATG3, ATG10 [161]

GBM

EGFRvIII [177]

NR

Melanoma

CD63, Caveolin1, TYRP2, VLA-4, HSP70 [110]

LC3β [178]

lung

EpCAM, EGFR, CEA, LRG-1 [179]

LC3β [180], Beclin-1 [174]

Ovarian

MAGE3/6, Claudin-4, L1CAM, TGFβ1, CD24, ADAM10, EMMPRIN [181]

NR

Pancreatic

GPC1, MIF [182]

NR

Prostate

Survivin, PTEN, Transmembranes, Protease, ITGB1, Serine2-ETS, β-catenin, PSA, PCA3, PSMA, ITGA3 [183]

NR

  1. NR means not recorded